📰 Reshape Lifescience News
Reshape Lifescience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reshape Lifescience. Real-time updates on events, politics, business and more.
May 29, 2024
ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application entitled, "Intragastric Device (For Treating Obesity)." In the patent filings, the company described the product as a swallowable implant that expands via a balloon in the stomach to induce a feeling of fullness, helping to restrict food intake.
December 31, 2023
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Profitability This table compares Vivos Therapeutics and […]
November 12, 2023
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences third quarter 2023 earnings call.
August 9, 2023
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023 earnings call.
May 5, 2023
Sigyn Therapeutics (OTCMKTS:SIGY – Get Rating) and ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Volatility & Risk Sigyn Therapeutics has a beta of […]
December 22, 2022
SAN CLEMENTE, Calif., Dec. 22, 2022 -- ReShape Lifesciences Inc. , the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has... | December 22, 2022
August 10, 2022
FinancialContent fully hosted finance channel
June 6, 2022
Valeritas (OTCMKTS:VLRXQ – Get Rating) and ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends. Insider & Institutional Ownership 16.9% of ReShape Lifesciences shares are […]